Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)
To access this article, please choose from the options below
PII: S0169-5002(08)00062-7
doi:10.1016/j.lungcan.2008.02.015
© 2008 Elsevier Ireland Ltd. All rights reserved.
